Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib

Journal of Thoracic Oncology

Volumn 7, Issue 7, 2012, Pages 1200-1201

  Pennell, Nathan A ^a   Yin, Lihong ^a   Keshtgarpour, Mani ^a   Ma, Patrick C ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PACLITAXEL; TAMOXIFEN;

ACNE; ADULT; ADVANCED CANCER; AGED; ANTIBIOTIC THERAPY; BREAST CANCER; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; FAMILY HISTORY; FEMALE; GENE DELETION; HUMAN; LUNG ADENOCARCINOMA; LUNG INFILTRATE; MALE; MASTECTOMY; MEDICAL HISTORY; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SMOKING; THORAX PAIN; THORAX RADIOGRAPHY; TRANSTHORACIC BIOPSY; TREATMENT RESPONSE;

EID: 84862900990     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318250ed89     Document Type: Article

References (5)

1. Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol 2007;25:587-595. (Pubitemid 350002967)
2. Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 2005;37:1315-1316. (Pubitemid 41722184)
3. Tibaldi C, Giovannetti E, Vasile E, et al. Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients. J Thorac Oncol 2011;6:395-396.
4. Girard N, Lou E, Azzoli CG, et al. Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clin Cancer Res 2010;16:755-763.
5. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075.